Researchers and scientists have spent the last 25 years trying and failing to develop effective treatments for many unmet needs including brain diseases. The majority of the traditional treatments methods available can’t bypass the blood brain barrier, leaving the majority of the medication behind in the nasal cavity, sinuses, or GI tract. Other methods also can produce a number of undesirable side effects.

Chronic Sinusitis is the largest clinical unmet need in the U.S. according to the Mayo Clinic. Over 30 million patients in the U.S. suffer from this condition with another 2 billion worldwide. Delivery technology and a reformulated corticosteroid is the answer Kurve brings.

ViaNase™ Intelligent Delivery holds the key to overcoming these frustrating obstacles. This modified approach to treating Systemic and Central Nervous System disorders uses Kurve Therapeutics’ patented Controlled Particle Dispersion® technology to deliver medication precisely where it is needed, providing relief and a sense of wellbeing for patients battling brain disease.